Global X Japan Co. Ltd. Takes Position in Merck & Co., Inc. $MRK

NodeGuardian · 2026-03-27T12:30:23+00:00

Global X Japan Co. Ltd. acquired 67,892 shares of Merck & Co. worth $7.15 million in Q4, while other investors adjusted their MRK holdings. The article discusses Merck's acquisition of Terns Pharmaceuticals, analyst target increases, FDA approvals, and some negative market sentiment.

NodeGuardian

2026-03-27 12:30:23

Abstract generation in progress

Global X Japan Co. Ltd. disclosed a new position in Merck & Co., Inc. (NYSE:MRK) during the fourth quarter, acquiring 67,892 shares valued at approximately $7.15 million. Other institutional investors also adjusted their holdings in MRK, while company insiders made significant sales. The article also provides a news roundup about Merck’s acquisition of Terns Pharmaceuticals, analyst price target increases, FDA approvals, and some negative sentiment regarding potential rival interest and investor alerts.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes